In summary, claudins -2, -4 and -18 were positively expressed in all pancreatic preneoplastic lesions, including hyperplastic foci, adenomas, IPMN, and MSN lesions, with different trends (Table 1 and Table 2). The gene discussed is CLDN2; the disease is pancreatic intraductal papillary-mucinous neoplasm.